Correspondence
Research Correspondence
Long-Term Hepatic Safety of Ambrisentan in Patients With Pulmonary Arterial Hypertension

https://doi.org/10.1016/j.jacc.2012.03.025Get rights and content
Under an Elsevier user license
open archive

Cited by (0)

Please note: All authors are employees of Gilead Sciences, Inc., and own Gilead Sciences stock and/or stock options.

Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.